federal_register: 2013-26570
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-26570 | Draft Guidance for Industry on Bioequivalence Recommendations for Iron Sucrose; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Bioequivalence Recommendations for Iron Sucrose." The recommendations provide specific guidance on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for iron sucrose injection. The draft guidance is a revised version of a previously issued draft guidance on the same subject. | 2013-11-06 | 2013 | 11 | https://www.federalregister.gov/documents/2013/11/06/2013-26570/draft-guidance-for-industry-on-bioequivalence-recommendations-for-iron-sucrose-availability | https://www.govinfo.gov/content/pkg/FR-2013-11-06/pdf/2013-26570.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Bioequivalence Recommendations for Iron Sucrose." The recommendations provide specific guidance on the design of bioequivalence (BE)... |